Abstract:
BACKGROUND:MAP0004 is a novel orally inhaled formulation of dihydroergotamine mesylate (DHE) currently in development that has been clinically observed to provide rapid ( approximately 10 minutes) therapeutic levels of DHE but with lower rates of adverse effects (dizziness, nausea, and paresthesia) compared with intravenous (IV) dosing. Receptor-based mechanistic studies were conducted to determine if differences between IV DHE and inhaled DHE (MAP0004) binding and functional activity were responsible for the improved adverse event profile. METHODS:Radioligand competitive binding assays were performed at adrenergic (alpha1 [non-specific], alpha2A, alpha2B, alpha2C, beta), dopaminergic (D; D(1), D(2), D(3)), and at serotonergic (5-HT; 5-HT(1A), 5-HT(1B), 5-HT(1D), 5-HT(2A), 5-HT(2C), 5-HT(3), 5-HT(4), 5-HT(5A), 5-HT(6), 5-HT(7)) receptors. Binding assays were also conducted for the major metabolite of DHE, 8'-hydroxy-DHE (8'-OH-DHE). Subsequent functional receptor assays were also performed at 5-HT(1B), 5-HT(1D), 5-HT(2A), 5-HT(2C), 5-HT(3), D(2), alpha1A, alpha2A, alpha2B, beta1, and beta2 and muscarinic receptors to ensure that observed receptor binding translated into potential functional response. RESULTS:For competitive binding studies, DHE demonstrated extensive activity at IV C(max) for all 5-HT receptors tested, except 5-HT(3) and 5-HT(4), and alpha1, alpha2A, alpha2B, alpha2C, and D(3) receptors. DHE concentrations used in the studies were equal to the peak plasma concentrations (C(max)) observed in human subjects following IV DHE 1.0 mg (the standard approved dose), and 2 and 4 inhalations MAP0004 which, respectively, produced systemic circulation levels of DHE equivalent to 0.44 mg and 0.88 mg administered IV. MAP0004 binding activity at the C(max) concentrations was lower than IV DHE and no binding was observed for the 8'-OH-DHE metabolite. However, MAP0004 preserved potent agonist action at key anti-migraine 5-HT(1B) and 5-HT(1D) receptors, even at the lower C(max )concentrations. Functional binding studies displayed similar results whereby IV DHE C(max) concentrations invoked strong agonist/antagonist responses, for instance at adrenergic and 5-HT(2C) receptors, which could have been responsible for dizziness. Conversely, at C(max) concentrations of MAP0004, inhaled DHE achieved a significantly lower response or no response at the adrenergic and 5-HT(2C) receptors. CONCLUSIONS:The mechanism by which nausea was experienced with IV DHE--yet not with MAP0004--was not associated with classic nausea pathways/targets (dopamine, 5-HT(3), or muscarinic receptors) or with peripheral action in the intestine via enterochromaffin cells. Importantly, the maximum DHE concentrations following MAP0004 administration were insufficient to interact with receptors implicated in cardiovascular (5-HT(2B) and beta(1)) and pulmonary effects (beta(2), adenosine, muscarinic, and leukotriene).
journal_name
Headachejournal_title
Headacheauthors
Cook RO,Shrewsbury SB,Ramadan NMdoi
10.1111/j.1526-4610.2009.01510.xsubject
Has Abstractpub_date
2009-11-01 00:00:00pages
1423-34issue
10eissn
0017-8748issn
1526-4610pii
HED1510journal_volume
49pub_type
杂志文章相关文献
HEADACHE文献大全abstract::Several second-generation triptans have been introduced that differ in their pharmacologic profiles relative to each other and to sumatriptan. As therapeutic options multiply, clinicians must be able to distinguish among these compounds. Recently, a meta-analysis was conducted on data from 53 double-blind, randomized,...
journal_title:Headache
pub_type: 杂志文章
doi:10.1046/j.1526-4610.2002.0420s1018.x
更新日期:2002-01-01 00:00:00
abstract:BACKGROUND:In previous studies, pregnancy has been associated with less headache, but the influence of parity on this association is largely unknown. OBJECTIVES:To examine the prevalence of headache and migraine among pregnant women, and explore the relation of headache to parity in a large, population-based study. M...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2009.01438.x
更新日期:2009-06-01 00:00:00
abstract::The treatment of migraine was transformed in 1992 with the introduction of the first triptan-based therapy, subcutaneous (SC) sumatriptan. SC sumatriptan has high efficacy and a rapid onset of action compared with other available triptans and formulations presumably because of its short Tmax, high Cmax, and avoidance ...
journal_title:Headache
pub_type: 杂志文章,评审
doi:10.1111/head.12183
更新日期:2013-09-01 00:00:00
abstract::In order to obtain data regarding peripheral levels of beta-endorphin in head pain syndromes, we evaluated the plasma beta-endorphin secretory pattern in 12 adult male patients suffering from cluster headache. Blood samples were drawn every 2 hours for a 24-hour period, and in addition at 30-minute intervals for 120 m...
journal_title:Headache
pub_type: 杂志文章
doi:10.1046/j.1526-4610.1996.3610603.x
更新日期:1996-11-01 00:00:00
abstract::We report the case of a man who suffered from Valsalva-induced cluster headaches. The headaches deviated from classic cluster in that they were solely induced by activity involving the Valsalva maneuver, such as coughing and sneezing, and never occurred spontaneously. The attacks were prevented by treatment with indom...
journal_title:Headache
pub_type: 杂志文章
doi:10.1046/j.1526-4610.2002.02088.x
更新日期:2002-04-01 00:00:00
abstract:OBJECTIVE:To evaluate the efficacy of ubrogepant on patient-reported functional disability, satisfaction with study medication, and global impression of change. BACKGROUND:Ubrogepant is a small-molecule, oral calcitonin gene-related peptide receptor antagonist indicated for the acute treatment of migraine. In 2 phase ...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/head.13766
更新日期:2020-04-01 00:00:00
abstract::Episodic cluster headache is a well-recognized entity usually starting in the second decade of life. Uncommonly, the first typical symptoms may present in the first decade of life, but are rarely recognized as such during childhood. We report a 12-year-old girl who presented with a 1-year history of bouts of right-sid...
journal_title:Headache
pub_type: 杂志文章
doi:10.1046/j.1526-4610.1997.3705296.x
更新日期:1997-05-01 00:00:00
abstract::Botulinum toxin A used to treat headache evokes prominent placebo effects and it is likely that these effects are solely responsible for its apparent effectiveness. ...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2011.01915.x
更新日期:2011-06-01 00:00:00
abstract::To assess the burden of migraine, we compared the productivity and the perceived health of 991 migraine sufferers (IHS criteria), 1,004 other-headache sufferers, and 1,757 nonheadache sufferers randomly chosen among volunteers from employees of the French national gas and electricity company. The extent of absenteeism...
journal_title:Headache
pub_type: 杂志文章
doi:10.1046/j.1526-4610.1997.3702071.x
更新日期:1997-02-01 00:00:00
abstract::This is a case report of a 15-year-old boy who developed benign intracranial hypertension after 3 weeks of levofloxacin intake. The headache, diplopia, and papilledema resolved within a week after levofloxacin was withdrawn. Physicians must be aware that quinolone antibiotics can potentially cause intracranial hyperte...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2008.01212.x
更新日期:2009-02-01 00:00:00
abstract:OBJECTIVE:To describe a case series of 7 patients presenting cluster headache (CH) criteria and a substance use disorder, reported to a French Addictovigilance center. Then, to assess clinical, pharmacological, and neurobiological linkages between substance use and CH onset. BACKGROUND:CH patients are presenting a hig...
journal_title:Headache
pub_type: 杂志文章,评审
doi:10.1111/head.13516
更新日期:2019-04-01 00:00:00
abstract::The Monks of Athos in Greece constitute a particular group with unusual sleep schedule and specific diet. In order to study the frequency of headache among them, a special questionnaire was designed. Four hundred forty-nine monks below the age of 50 were approached, 39 of whom suffered from frequent (more than one epi...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.1994.hed3409539.x
更新日期:1994-10-01 00:00:00
abstract:BACKGROUND:Past studies have reported that connective tissue disorders (CTDs) are more common in patients with specific types of headache disorders. OBJECTIVES:The objectives of this study are (1) to review and critique the clinical studies reporting an association between joint hypermobility, CTDs and headache and (2...
journal_title:Headache
pub_type: 杂志文章,评审
doi:10.1111/head.12417
更新日期:2014-09-01 00:00:00
abstract::Pain has been considered as part of a defensive strategy whose specific role is to signal an immediate active danger to the organism. This definition fits well for acute pain. It does not work well, however, for chronic pain that is maintained even in absence of an ongoing, active threat. Currently, acute and chronic ...
journal_title:Headache
pub_type: 杂志文章,评审
doi:10.1111/j.1526-4610.2012.02244.x
更新日期:2012-10-01 00:00:00
abstract:OBJECTIVES:The purpose of this study was to evaluate the course of headache in patients with moderate-to-severe headache due to aneurysmal subarachnoid hemorrhage (aSAH) and to identify its predisposing factors. BACKGROUND:Little is known about the long-term course of headache in patients with aSAH. METHODS:Since Sep...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/head.12612
更新日期:2015-07-01 00:00:00
abstract::A retrospective study was conducted on 1300 women suffering from migraine without aura referred to the Headache Centers of Parma and Pavia from 1984 to 1990. All the data concerning their reproductive life, and the modifications induced by it on the course of headache were obtained from record-charts. Migraine frequen...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.1993.hed3307385.x
更新日期:1993-07-01 00:00:00
abstract:OBJECTIVE:To investigate whether intravenously infused provokes migraine aura and migraine headache in migraine patients with aura. BACKGROUND:Migraine with aura has been associated with endothelial dysfunction and increased stroke risk. The initiating mechanism of migraine aura symptoms is not known. Experimental pro...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/head.13753
更新日期:2020-04-01 00:00:00
abstract::It is to be expected that differences in electrical activity of the brain between migraine patients with aura and those without aura can only be revealed by stimuli that provoke visual spatial processing, i.e. stimuli that trigger so called endogenous Visual Evoked Potential (VEP) activity. This is not the case for th...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.1993.hed3308413.x
更新日期:1993-09-01 00:00:00
abstract:OBJECTIVE:To examine circadian and menstrual patterns of migraine frequency in order to identify properties of the putative migraine generator. METHODS:Analysis of circadian and menstrual migraine attack frequency distributions, using between-interval differences as estimates, at each time point, of the derivative of ...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2005.05134.x
更新日期:2005-07-01 00:00:00
abstract:OBJECTIVE:Using a "double-pulse" adaptation paradigm, in which two stimuli are presented in quick succession, this study examines the neural mechanisms underlying potentiation of the visual evoked potential (VEP) in visual snow syndrome. BACKGROUND:Visual snow is a persistent visual disturbance characterized by rapid ...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/head.13231
更新日期:2018-01-01 00:00:00
abstract:OBJECTIVE:To determine the pharmacological profile of frovatriptan. BACKGROUND:Frovatriptan is a new 5-HT(1B/1D) agonist developed for the treatment of migraine. METHODS:Pharmacological studies were performed using in vitro and in vivo techniques. RESULTS:Radioligand-binding studies showed that frovatriptan has a hi...
journal_title:Headache
pub_type: 杂志文章
doi:10.1046/j.1526-4610.42.s2.2.x
更新日期:2002-04-01 00:00:00
abstract::Recently, it has become obvious that disabling postoperative headache is a major problem with acoustic neuroma surgery. A questionnaire was used to retrospectively evaluate the incidence, clinical features, prognosis and possible therapeutic measures of this particular form of headache. Forty-two percent (42%) of pati...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.1995.hed3502098.x
更新日期:1995-02-01 00:00:00
abstract:OBJECTIVE:To compare the efficacy and tolerability of sumatriptan nasal spray (NS) (5, 20 mg) versus placebo in the acute treatment of migraine in adolescent subjects. BACKGROUND:Currently, no triptan is approved in the United States for the treatment of migraine in adolescent subjects (12 to 17 years). In a previous ...
journal_title:Headache
pub_type: 杂志文章,多中心研究,随机对照试验
doi:10.1111/j.1526-4610.2006.00339.x
更新日期:2006-02-01 00:00:00
abstract:BACKGROUND:A vascular component in ergotamine-induced headache has been proposed. No study has been carried out to evaluate cerebral hemodynamic changes by means of transcranial Doppler during withdrawal from migraine medication; in particular, ergotamine-containing drugs. METHOD:We examined 21 patients suffering from...
journal_title:Headache
pub_type: 杂志文章
doi:10.1046/j.1526-4610.1998.3809679.x
更新日期:1998-10-01 00:00:00
abstract:OBJECTIVE:Presentation of pooled analysis of safety data for fremanezumab in patients with chronic (CM) or episodic migraine (EM) from 4 placebo-controlled phase 2b and phase 3 studies. BACKGROUND:There is a need for an effective, safe, and well-tolerated preventive therapy that specifically targets the pathophysiolog...
journal_title:Headache
pub_type: 杂志文章,meta分析
doi:10.1111/head.13534
更新日期:2019-06-01 00:00:00
abstract:OBJECTIVES:To describe the occurrence of cerebral venous thrombosis in a 40-year-old man whose cerebral event was induced by a poor golf swing, to review the literature on possible mechanisms producing venous thrombosis, and to compare this case with the literature. BACKGROUND:Headache is the most frequent symptom in ...
journal_title:Headache
pub_type: 杂志文章,评审
doi:10.1046/j.1526-4610.2000.00093.x
更新日期:2000-07-01 00:00:00
abstract::The majority of research conducted on headache has utilized cross-sectional designs which preclude the examination of dynamic factors and principally rely on group-level effects. The present article describes the application of an individual-oriented process model using time-series analytical techniques. The blending ...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2005.05095.x
更新日期:2005-05-01 00:00:00
abstract:OBJECTIVES:Migraine is a common disabling neurological disorder. Current acute treatments for migraine in adolescents are mostly pharmacological and may have limited effectiveness, can cause side effects, and may lead to medication overuse. There is an unmet need for effective and well-tolerated treatments. Remote elec...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/head.14042
更新日期:2020-12-21 00:00:00
abstract:BACKGROUND:Frequent, excessive use of over-the-counter or prescription analgesics may lead to analgesic rebound headache. Little is known about the magnitude of the health problem posed by analgesic rebound headache, its epidemiology, the characteristics of analgesic rebound headache sufferers, or about physicians' app...
journal_title:Headache
pub_type: 杂志文章
doi:10.1046/j.1526-4610.1996.3601014.x
更新日期:1996-01-01 00:00:00
abstract:BACKGROUND:Patients with chronic kidney disease who need dialysis often have poor quality of life. Dialysis headache is a frequent complication of hemodialysis and is often a challenge for nephrologists, neurologists, and headache specialists. METHOD:This was a narrative review. RESULTS:The prevalence of dialysis hea...
journal_title:Headache
pub_type: 杂志文章,评审
doi:10.1111/head.12875
更新日期:2017-01-01 00:00:00